86 research outputs found

    Anti Urolithiatic and anti hyperlipidemic activity of Coleus aromaticus An explanation of the underlying mechanisms

    Get PDF
    Leaves paste of Coleus aromaticus is used as a traditional remedy for urolithiasis in India. In the present study, the anti urolithiatic activity of Coleus aromaticus was investigated in ethylene glycol induced urolithiatic rats. There was a significant increase in the levels of calcium oxalate crystals in the kidneys as well as lipid levels in the blood serum. Treatment with hydro alcoholic extract of C.aromaticus leaves (CALHAE) significantly reduced cholesterol levels at 300 and 600 mg/kg, and triglyceride levels at 600 mg/kg in urolithiatic rats. Histopathalogical reports confirmed that chronic administration of CALHAE (300 and 600 mg/kg) diminished number of calcium oxalate crystals in kidneys. CALHAE has shown reduction in thiobarbituric acid reactive substances (TBARS) in urolithiatic rats. Moreover, CALHAE showed potent in vitro antioxidant activity in DMPD, ABTS radicals (MnO2 method). Results from these studies support the safe and effective use of C.aromaticus leaves for urolithiasis treatment.Keywords: Coleus aromaticus, Calcium oxalate crystals, Hypolipidemic activity, Antioxidant activit

    Optical, morphological and photocatalytic properties of biobased tractable films of chitosan/donor-acceptor polymer blends

    Get PDF
    Biobased tractable films consisting of blends of chitosan (CS) with polymer bearing carbazole derivatives as pendant groups and fluorene-thiophene as donor-acceptor units (referred to as DA) were prepared, and their optical, morphological and photocatalytic properties were studied. DA was dissolved in tetrahydrofuran (THF) and mixed with an acidified aqueous solution containing chitosan to obtain chitosan/DA (CS/DA) films by solution casting. The fabricated biobased films were characterized using spectroscopic techniques (FT-IR and UV–vis), thermogravimetry, mechanical assays, contact angle analysis, and atomic force microscopy (AFM). The effects of varying DA compositions and the results of exposure to visible-light irradiation of the films were also analyzed. The results indicated the existence of interactions between chitosan and DA and a potentially profitable light-driven response of these biobased films. This behavior was reflected in the optical, topographical, and contact angle properties of the films, which exhibited different characteristics before and after visible-light exposure. Finally, the photocatalytic performance of the biobased films was tested via the decomposition of methyl orange (MO), as a reaction model system. Our results revealed a significant photocatalytic activity (according to biobased film composition, approximately 64 % and 87 % of methyl orange were degraded under continuous visible-light irradiation for 120 min) of the films which is attributed to the combined presence and synergetic effects of the film-forming ability of chitosan and the photoproperties of DA

    Effect of angiotensin-converting enzyme inhibitor and angiotensin receptor blocker initiation on organ support-free days in patients hospitalized with COVID-19

    Get PDF
    IMPORTANCE Overactivation of the renin-angiotensin system (RAS) may contribute to poor clinical outcomes in patients with COVID-19. Objective To determine whether angiotensin-converting enzyme (ACE) inhibitor or angiotensin receptor blocker (ARB) initiation improves outcomes in patients hospitalized for COVID-19. DESIGN, SETTING, AND PARTICIPANTS In an ongoing, adaptive platform randomized clinical trial, 721 critically ill and 58 non–critically ill hospitalized adults were randomized to receive an RAS inhibitor or control between March 16, 2021, and February 25, 2022, at 69 sites in 7 countries (final follow-up on June 1, 2022). INTERVENTIONS Patients were randomized to receive open-label initiation of an ACE inhibitor (n = 257), ARB (n = 248), ARB in combination with DMX-200 (a chemokine receptor-2 inhibitor; n = 10), or no RAS inhibitor (control; n = 264) for up to 10 days. MAIN OUTCOMES AND MEASURES The primary outcome was organ support–free days, a composite of hospital survival and days alive without cardiovascular or respiratory organ support through 21 days. The primary analysis was a bayesian cumulative logistic model. Odds ratios (ORs) greater than 1 represent improved outcomes. RESULTS On February 25, 2022, enrollment was discontinued due to safety concerns. Among 679 critically ill patients with available primary outcome data, the median age was 56 years and 239 participants (35.2%) were women. Median (IQR) organ support–free days among critically ill patients was 10 (–1 to 16) in the ACE inhibitor group (n = 231), 8 (–1 to 17) in the ARB group (n = 217), and 12 (0 to 17) in the control group (n = 231) (median adjusted odds ratios of 0.77 [95% bayesian credible interval, 0.58-1.06] for improvement for ACE inhibitor and 0.76 [95% credible interval, 0.56-1.05] for ARB compared with control). The posterior probabilities that ACE inhibitors and ARBs worsened organ support–free days compared with control were 94.9% and 95.4%, respectively. Hospital survival occurred in 166 of 231 critically ill participants (71.9%) in the ACE inhibitor group, 152 of 217 (70.0%) in the ARB group, and 182 of 231 (78.8%) in the control group (posterior probabilities that ACE inhibitor and ARB worsened hospital survival compared with control were 95.3% and 98.1%, respectively). CONCLUSIONS AND RELEVANCE In this trial, among critically ill adults with COVID-19, initiation of an ACE inhibitor or ARB did not improve, and likely worsened, clinical outcomes. TRIAL REGISTRATION ClinicalTrials.gov Identifier: NCT0273570

    Synthesis of nanocrystalline nickel-iron alloys-A novel chemical reduction method

    No full text
    Ultra fine magnetic particles of NixFe100-x alloys were synthesized by a novel chemical reduction of the precursor salts by an alkali earth metal (Al) in an aqueous medium. In this method we successfully prepared alloy nanocrystalline powders without any bimetallic phases. The alloys were formed with Fe at% in two distinct bands 18–30 and 60–90 irrespective of the concentration ratios of Ni and Fe sources. The NixFe100-x alloy composition showed a transformation from fcc to bcc structure .The Ni rich alloys namely NixFe100-x (x = 90 to75) which correspond to 18–30 band Fe at%.composition were formed in fcc (or simple cubic) phase, whereas the Fe rich alloys (x = 80) which correspond to 66–90 band Fe at%.composition were formed in bcc phase. The observed grain sizes for Ni rich (i.e., 18–30 Fe at.%) alloys lie in the range of 6–9 nm whereas for the Fe rich alloys grains are in the 20–27 nm range. Magnetization measurements shows that all the alloys exhibit ferromagnetic behaviour and the saturation magnetization values increase linearly with iron content. Vibrating sample magnetometer measurements shows that all samples exhibit ferromagnetic behaviour with increasing saturation magnetization as a function of iron content. SEM studies shows that the particles were found be large and agglomerated